EGFR Inhibitor CO-1686

An orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity. EGFR inhibitor CO-1686 binds to and inhibits mutant forms of EGFR, including T790M, thereby leading to cell death of resistant tumor cells. Compared to other EGFR inhibitors, CO-1686 inhibits T790M, a secondary acquired resistance mutation, as well as other mutant EGFRs and may have therapeutic benefits in tumors with T790M-mediated resistance to other EGFR tyrosine kinase inhibitors. This agent shows minimal activity against wild-type EGFR, hence does not cause certain dose-limiting toxicities. (NCI Thesaurus)

YOU MAY ALSO LIKE

EGFR Inhibitor ABT-414

An epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon intravenous infusion, ABT-414 inhibits the activity of EGFR, thereby preventing…

EGFR inhibitor

A substance that blocks the activity of a protein called epidermal growth factor receptor (EGFR). EGFR is found on the surface of…

EGFR Gene Product

A protein encoded by the EGFR gene.

EGFR Gene Mutation

A change in the nucleotide sequence of the EGFR gene.

EGFR Gene

This gene is involved in the epidermal growth factor signal transduction pathway.

EGFR CAR-CD3zeta-4-1BB-expressing Autologous T-Lymphocytes

Autologous human T-lymphocytes transduced with a retroviral vector encoding an anti-epidermal growth factor receptor (EGFR) chimeric T cell receptor (chimeric antigen receptor…